Stuart Beth, Rumsby Kate, Santer Miriam, Ridd Matthew J, Francis Nick A, Chorozoglou Maria, Spreadbury Carla, Steele Mary, Nollett Claire, Liddiard Lyn, Prude Martina, Hooper Julie, Thomas-Jones Emma, Roberts Amanda, Thomas Kim S, Williams Hywel C, Little Paul
Department of Primary Care and Population Sciences, University of Southampton, Aldermoor Health Centre, Aldermoor Close, Southampton, SO16 5ST, UK.
School of Social and Community Medicine, University of Bristol, Bristol, UK.
Trials. 2018 Oct 24;19(1):582. doi: 10.1186/s13063-018-2962-3.
Patient-reported outcomes measures in clinical trials ensure that evaluations of effectiveness focus on outcomes that are important to patients. In relapsing-remitting conditions, such as eczema, repeated measurements may allow a more accurate reflection of disease burden and treatment effect than less frequent measurements. We asked parents/carers of children with eczema taking part in a trial of bath emollients to complete weekly questionnaires for 16 weeks.
The objective of this study was to determine the acceptability and practicality of collecting weekly measures of eczema severity online for 16 weeks in children aged 1 to 11 years as part of the BATHE study. BATHE randomised patients to bath emollients plus standard eczema care or standard eczema care only. The primary outcome was eczema severity, measured by the seven-item Patient-Oriented Eczema Measure (POEM) repeated weekly for 16 weeks. Acceptability was explored through qualitative interviews with 10 participants. Interviews were audio-recorded, transcribed and analysed thematically. Practicality was assessed by exploring the completeness of the data and keeping a log of any problems.
Four hundred and eighty-two participants were recruited to the trial and 429 opted to complete measures online (89.0%). Data were collected online for 83% of time points over the 16-week period and there was no association between socio-demographic characteristics and data completeness. Two hundred and six (48%) completed their weekly data every week for 16 weeks and 341 (79%) completed it at least 80% of the time. The mean number of weeks completed was 13.3 out of 16 (SD 4.2). Interviewees said that they understood the rationale behind weekly collection and some welcomed this as it helped them realise how their child's eczema changed weekly. Whilst some interviewees spoke of weekly questionnaires as onerous, others said that they found them quick and easy. Reminders were welcomed. Parents/carers seemed happy to receive telephone reminders and it was sometimes useful for eliciting problems relating to obtaining trial medication or password problems for online data collection.
Amongst this population, high levels of data completeness suggests that weekly completion of the online questionnaire appears to be acceptable and feasible over a 16-week period.
ISRCTN84102309 . Registered on 9 December 2013.
临床试验中患者报告的结局指标可确保对有效性的评估聚焦于对患者重要的结局。在复发缓解性疾病(如湿疹)中,与较少频率的测量相比,重复测量可能能更准确地反映疾病负担和治疗效果。我们让参与沐浴润肤剂试验的湿疹患儿的父母/照料者填写16周的每周问卷。
本研究的目的是确定作为BATHE研究的一部分,在1至11岁儿童中连续16周在线收集湿疹严重程度每周测量数据的可接受性和实用性。BATHE将患者随机分为沐浴润肤剂加标准湿疹护理组或仅标准湿疹护理组。主要结局是湿疹严重程度,通过七项患者导向性湿疹量表(POEM)每周重复测量,共16周。通过对10名参与者进行定性访谈来探索可接受性。访谈进行录音、转录并进行主题分析。通过探究数据的完整性并记录任何问题来评估实用性。
482名参与者被招募到该试验中,429人选择在线完成测量(89.0%)。在16周期间,83%的时间点的数据是在线收集的,社会人口学特征与数据完整性之间没有关联。206人(48%)在16周内每周都完成了他们的每周数据,341人(79%)至少80%的时间完成了数据。完成的平均周数为16周中的13.3周(标准差4.2)。受访者表示他们理解每周收集数据背后的基本原理,一些人对此表示欢迎,因为这有助于他们了解孩子的湿疹每周是如何变化的。虽然一些受访者称每周问卷很繁琐,但另一些人表示他们觉得问卷快速且容易填写。提醒受到欢迎。父母/照料者似乎很高兴收到电话提醒,这有时有助于引出与获取试验药物或在线数据收集的密码问题相关的问题。
在这一人群中,较高的数据完整性表明在16周期间每周完成在线问卷似乎是可接受且可行的。
ISRCTN84102309。于2013年12月9日注册。